N-氟-3,5-二氯吡啶三氟 | 107264-06-2

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: N-氟-3,5-二氯吡啶三氟
• 英文名称: 1-fluoro-3,5-dichloropyridinium trifluoromethanesulfonate
• 英文别名: 3,5-dichloro-N-fluoropyridinium triflate；N-fluoro-3,5-dichloropyridinium triflate；N-fluoro-3,5-dichloropyridinium trifluoromethanesulfonate；3,5-dichloro-1-fluoro-pyridinium triflate；3,5-dichloro-1-fluoropyridinium triflate；1-Fluoro-3,5-dichloropyridinium triflate；3,5-dichloro-1-fluoropyridin-1-ium;trifluoromethanesulfonate
• CAS: 107264-06-2
• 化学式: CF₃O₃S*C₅H₃Cl₂FN
• 分子量: 316.06
• InChiKey: ZSTJMYZXBGCMIG-UHFFFAOYSA-M

物化性质

• 熔点：
  107-112°C
• 密度：
  1.709 (estimate)
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  2.06
• 重原子数：
  17
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  69.5
• 氢给体数：
  0
• 氢受体数：
  7

安全信息

• 危险等级：
  8
• 危险品标志：
  Xi,C
• 安全说明：
  S26
• 危险类别码：
  R34
• 海关编码：
  2933399090
• 包装等级：
  III
• 危险品运输编号：
  UN 3261
• 储存条件：
  存储于0至6℃的阴凉干燥环境中

SDS

Name:	N-Fluoro-3,5-Dichloropyridinium Triflate, 90-95% Material Safety Data Sheet
Synonym:	None known.
CAS:	107264-06-2

Section 1 - Chemical Product MSDS Name: N-Fluoro-3,5-Dichloropyridinium Triflate, 90-95% Material Safety Data Sheet
Synonym: None known.

---

SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
107264-06-2	N-Fluoro-3,5-Dichloropyridinium Trifla	90-95	unlisted

Hazard Symbols: C
Risk Phrases: 34

---

SECTION 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW Causes burns.Moisture sensitive.Light sensitive.Corrosive. Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal damage.
Skin:
Causes skin burns. May cause skin rash (in milder cases), and cold and clammy skin with cyanosis or pale color.
Ingestion:
May cause severe and permanent damage to the digestive tract. Causes gastrointestinal tract burns. May cause perforation of the digestive tract. The toxicological properties of this substance have not been fully investigated. May cause systemic effects.
Inhalation:
May cause severe irritation of the respiratory tract with sore throat, coughing, shortness of breath and delayed lung edema. Causes chemical burns to the respiratory tract. The toxicological properties of this substance have not been fully investigated. Aspiration may lead to pulmonary edema. May cause systemic effects.
Chronic:
Effects may be delayed.

---

SECTION 4 - FIRST AID MEASURES
Eyes:
Get medical aid. Do NOT allow victim to rub eyes or keep eyes closed. Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:

---

SECTION 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Do NOT get water inside containers. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

SECTION 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation. Do not get water inside containers.

---

SECTION 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Minimize dust generation and accumulation. Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not ingest or inhale. Store protected from light. Do not allow contact with water. Discard contaminated shoes. Keep from contact with moist air and steam.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep refrigerated. (Store below 4C/39F.) Store protected from moisture. Store protected from light.

---

SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 107264-06-2: Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Solid
Color: slightly yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 98.00 - 101.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: 174 deg C ( 345.20 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 174 deg C
Solubility in water: reacts
Specific Gravity/Density:
Molecular Formula: C6H3Cl2F4NO3S
Molecular Weight: 316.04

---

SECTION 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, light, dust generation, moisture, excess heat.
Incompatibilities with Other Materials:
Moisture.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, oxides of sulfur, irritating and toxic fumes and gases, carbon dioxide, hydrogen fluoride gas, nitrogen.
Hazardous Polymerization: Has not been reported.

---

SECTION 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 107264-06-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-Fluoro-3,5-Dichloropyridinium Triflate - Not listed by ACGIH, IARC, or NTP.

---

SECTION 12 - ECOLOGICAL INFORMATION

---

SECTION 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations.

---

SECTION 14 - TRANSPORT INFORMATION IATA
Shipping Name: CORROSIVE SOLID, N.O.S.
Hazard Class: 8
UN Number: 1759
Packing Group: III IMO
Shipping Name: CORROSIVE SOLID, N.O.S.
Hazard Class: 8
UN Number: 1759
Packing Group: III RID/ADR
Shipping Name: CORROSIVE SOLID, N.O.S.
Hazard Class: 8
UN Number: 1759
Packing group: III

---

SECTION 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 28A After contact with skin, wash immediately with plenty of water. S 36/37/39 Wear suitable protective clothing, gloves and eye/face protection. S 37 Wear suitable gloves. S 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). WGK (Water Danger/Protection) CAS# 107264-06-2: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 107264-06-2 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 107264-06-2 is not listed on the TSCA inventory. It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
MSDS Creation Date: 9/02/1997 Revision #7 Date: 3/18/2003 The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-氟-3,5-二氯吡啶三氟 在 1-氟-2,4,6-三甲基吡啶三氟甲烷磺酸盐 作用下， 以 乙腈 为溶剂， 反应 2.17h， 生成 2-(3-fluoro-1-azulenyl)-3,5-dichloropyridine
  参考文献：
  名称：

  氟芴的合成与性质。二、用 N-氟试剂亲电氟化 Azulenes

  摘要：

  1-氟-和1,3-二氟-和1,3-二氟-和1-二氟-和1,3-二氟- azulenes 是第一次通过用N-氟试剂对azulenes 进行亲电氟化来合成。1-氟丁烯的选择性制备是通过甲基 azulene-1-carboxylates 的氟化，然后在 100% H3PO4 中脱甲氧基羰基化来进行的。2-取代的芘以更高的产率被氟化。在 1-氟芴的 1H NMR 中，与 1-氟萘相比，在 H-2 和 H-8 处未观察到长程 JFH 值。由于所谓的 +Iπ 效应，1-氟原子会导致薁的可见光吸收发生显着的红移。

  DOI：

  10.1246/bcsj.69.1645
• 作为产物：
  描述：

  (3,5-dichloropyridin-1-ium-1-yl)-trimethylsilane;trifluoromethanesulfonate 在 fluorine 作用下， 以 乙腈 为溶剂， 以55%的产率得到N-氟-3,5-二氯吡啶三氟
  参考文献：
  名称：

  N-Fluoropyridinium triflate and its analogs, the first stable 1:1 salts of pyridine nucleus and halogen atom

  摘要：

  DOI：

  10.1016/s0040-4039(00)84772-3
• 作为试剂：
  描述：

  二苯甲酰基甲烷 在 N-氟-3,5-二氯吡啶三氟 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 5.0h， 生成 2,2-二氟-1,3-二苯基-1,3-丙二酮 、 2-fluoro-1,3-diphenyl-1,3-propanedione
  参考文献：
  名称：

  功率和结构可变的氟化剂。N-氟吡啶鎓盐体系

  摘要：

  N-氟吡啶鎓盐提供了一种新的氟化剂系统，通过该系统，由于氟化能力的不同程度，反应性不同的各种亲核底物可以被氟化，并且还可以通过结构改变非常有选择性地氟化。在现有结果的基础上，选择性氟化的范围应该大大拓宽。因此，N-氟吡啶鎓盐系统应该可以制备许多有用的有机氟化合物

  DOI：

  10.1021/ja00179a047

文献信息

• 6-O-acyl ketolide antibacterials
  申请人：——

  公开号：US20030220272A1

  公开（公告）日：2003-11-27

  6-O-Acyl ketolide antibacterials of the formula: 1 wherein R 1 , R 2 , R 3 , R 4 , W, X, X′, Y, and Y′ are as described herein and in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents.

  其中R1、R2、R3、R4、W、X、X'、Y和Y'如本文所述，并且其中取代基具有描述中指示的含义。这些化合物可用作抗菌剂。
• 6-0-carbamoyl ketolide antibacterials
  申请人：——

  公开号：US20020115620A1

  公开（公告）日：2002-08-22

  6-O-Carbamoyl ketolide antibacterials of the formula: 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , X, X′, Y, and Y′ are as described herein and in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents.

  其中R1、R2、R3、R4、R5、R6、X、X'、Y和Y'如本文所述，并且其中取代基具有描述中指示的含义。这些化合物可用作抗菌剂。
• Inhibitors of &agr;4 mediated cell adhesion
  申请人：Tanabe Seiyaku Co., Ltd.

  公开号：US06521666B1

  公开（公告）日：2003-02-18

  The present invention relates to a pharmaceutical composition comprising as an active ingredient a compound of formula (I), wherein Ring A is an aromatic or a heterocyclic ring; Q is a bond, carbonyl, lower alkylene, lower alkenylene, —O-(lower alkylene)-, etc.; n is 0, 1 or 2; Z is oxygen or sulfur, W is oxygen, sulfur, —CH═CH—, —NH— or —N═CH—; R1, R2 and R3 are the same or different and are hydrogen, halogen, hydroxyl, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted lower alkoxy group, a substituted or unsubstituted amino group, etc.; R4 is tetrazolyl, carboxyl group, amide or ester; R5 is hydrogen, nitro, amino, hydroxyl, lower alkanoyl, lower alkyl etc.; R6 is selected from (a) a substituted or unsubstituted phenyl group, (b) a substituted or unsubstituted pyridyl group, (c) a substituted or unsubstituted thienyl group, (d) a substituted or unsubstituted benzofuranyl group, etc.; or a pharmaceutically acceptable salt thereof.

  本发明涉及一种包含作为活性成分的化合物的药物组合物，其中环A是芳香族或杂环环；Q是键，羰基，低烷基，低烯基，—O-(低烷基)-等；n为0、1或2；Z为氧或硫，W为氧、硫、—CH═CH—、—NH—或—N═CH—；R1、R2和R3相同或不同，为氢、卤素、羟基、取代或未取代的低烷基、取代或未取代的低烷氧基、取代或未取代的氨基等；R4为四唑基、羧基、酰胺或酯基；R5为氢、硝基、氨基、羟基、低烷酰基、低烷基等；R6选自(a)取代或未取代的苯基、(b)取代或未取代的吡啶基、(c)取代或未取代的噻吩基、(d)取代或未取代的苯并呋喃基等；或其药学上可接受的盐。
• Syntheses and Properties of<i>N</i>-Fluoropyridinium Salts
  作者：Teruo Umemoto、Kikuko Harasawa、Ginjiro Tomizawa、Kosuke Kawada、Kyoichi Tomita

  DOI：10.1246/bcsj.64.1081

  日期：1991.4

  counter anion displacement reactions of unstable pyridine-F2 compounds, fluorination of salts of pyridines with protonic acids or silyl esters with F2, and/ or fluorination of Lewis acid complexes of pyridines. The scope of each method was examined in detail. Each of the N-fluoropyridinium salts was assigned as the first stable 1 : 1 salt structure of the pyridine nucleus and halogen atom on the basis

  各种稳定的 N-氟吡啶鎓盐，带有非亲核性或弱亲核性抗衡阴离子，例如 TfO−、FSO3−、BF4−、SbF6−、ClO4−、CH3SO3− 等，或带有给电子或吸电子取代基合成了吡啶环上的化合物并研究了它们的性质。还合成了 N-氟吡啶鎓-2-磺酸盐、N-氟喹啉鎓三氟甲磺酸盐和高度受阻的 N-氟-2,6-二-叔丁基吡啶鎓盐。它们是通过不稳定的吡啶-F2 化合物的抗衡阴离子置换反应、吡啶盐与质子酸或甲硅烷基酯与 F2 的氟化和/或吡啶的路易斯酸络合物的氟化来合成的。详细检查了每种方法的范围。每种 N-氟吡啶鎓盐都被指定为第一个稳定的 1：1 基于光谱和元素分析的吡啶核和卤素原子的盐结构。稳定性取决于抗衡阴离子的亲核性或碱性以及环的电子性质或位置...
• NOVEL 11,12-SUBSTITUTED LACTONE KETOLIDE DERIVATIVES HAVING ANTIBACTERIAL ACTIVITY
  申请人：——

  公开号：US20040038915A1

  公开（公告）日：2004-02-26

  Novel 11-12 substituted lactone ketolide derivatives and pharmaceutically-acceptable compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically-acceptable carrier are described. Also described are a method for treating bacterial infections by administering to an animal a pharmaceutical composition containing a therapeutically effective amount of a compound of the invention and processes for the preparation of such compounds.

  描述了11-12位取代的乳酮酮类衍生物以及包含有效治疗量的本发明化合物和药用可接受载体的药用可接受组合物。还描述了一种通过向动物投给包含本发明化合物的有效治疗量的药物组合物来治疗细菌感染的方法，以及制备这些化合物的过程。

表征谱图